Pricing
Not listed
Official monthly price not confirmed
- API
- Not confirmed
Medical AI · Vendor site 2026-10-04
Nucleo automates oncology CT scan analysis for body composition, tumor lesion sizing, and RECIST-oriented lesion classification. The company advertises faster-than-manual segmentation with high expert agreement for hospital partners.
Hospital oncology teams and researchers seeking AI-assisted CT workflows for sarcopenia assessment and tumor measurement.
Go-to-market is demo-led via Book a demo forms without public subscription pricing.
Nucleo combines AI segmentation and classification to streamline three oncology imaging workflows with claims of major speedups versus manual reads.
What it can do
Unknown is different from unavailable. Each fact carries its own evidence.
| Capability | Value | Evidence | Checked |
|---|---|---|---|
| CT automation | Homepage headline states Nucleo automates CT scan analysis for oncology care. | Facts sourced | 2026-10-04 |
| Use cases | Site lists body composition, tumor lesion sizing, and target versus non-target lesion classification workflows. | Facts sourced | 2026-10-04 |
Understand the total cost
Pricing
Not listed
Official monthly price not confirmed
Pilot5 Legal uses multiple models to examine legal arguments, including an opposing view. Its workflows include separation-agreement review, clause explanation, statutory retrieval and settlement analysis, with sources and minority reasoning retained.
Explore toolStartories combines public buying-signal discovery, company and decision-maker matching, business-email verification and personalized outbound sequences. It advertises human targeting/message review, reply classification and stop-on-reply follow-ups.
Explore toolDriven combines model-assisted investment research with market data, options analysis, persistent agent workspaces and scheduled monitoring. It supports strategy portfolios and describes broker-connected order workflows, alongside reusable research skills.
Explore toolThe practical questions
Nucleo automates oncology CT scan analysis for body composition, tumor lesion sizing, and RECIST-oriented lesion classification. The company advertises faster-than-manual segmentation with high expert agreement for hospital partners.
Not confirmed. This record does not confirm an ongoing free plan.
A listed monthly price has not been confirmed. See the plan cards for entitlements, billing commitments and seat minimums.
Not confirmed. API access and subscription access may have different terms; consult the linked sources.
Go-to-market is demo-led via Book a demo forms without public subscription pricing.
No retained pricing changes yet. A current price alone does not establish a historical trend.
Reviewed vendor source
Read original source ↗Facts apply to the named version and check date. Send a sourced correction if something changed.